Advanced search
Publication Cover
Clinical Toxicology Volume 60, 2022 - Issue 9
Submit an article Journal homepage
530
Views
0
CrossRef citations to date
0
Altmetric
Short Communications

Tapentadol exposures and poisonings in Australia

Betty S. Chana Clinical Toxicology Unit, Emergency Department, Prince of Wales Hospital, Sydney, Australia;b New South Wales Poisons Information Centre, Sydney, Australia;c University of New South Wales, Sydney, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0083-282XView further author information
ORCID Icon,
Jennifer Mirabellac University of New South Wales, Sydney, AustraliaView further author information
,
Katherine Allend Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, AustraliaView further author information
,
Ingrid Berlingb New South Wales Poisons Information Centre, Sydney, Australia;e Department of Clinical Toxicology, Calvary Mater Newcastle, Newcastle, AustraliaView further author information
,
Angela L. Chiewa Clinical Toxicology Unit, Emergency Department, Prince of Wales Hospital, Sydney, Australia;b New South Wales Poisons Information Centre, Sydney, Australia;c University of New South Wales, Sydney, AustraliaORCID Iconhttps://orcid.org/0000-0002-0079-5056View further author information
ORCID Icon,
Katherine Isoardib New South Wales Poisons Information Centre, Sydney, Australia;d Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, AustraliaORCID Iconhttps://orcid.org/0000-0002-1176-7923View further author information
ORCID Icon,
Jared Brownb New South Wales Poisons Information Centre, Sydney, AustraliaORCID Iconhttps://orcid.org/0000-0001-6855-3865View further author information
ORCID Icon &
Geoffrey Isbisterb New South Wales Poisons Information Centre, Sydney, Australia;e Department of Clinical Toxicology, Calvary Mater Newcastle, Newcastle, AustraliaORCID Iconhttps://orcid.org/0000-0003-1519-7419View further author information
ORCID Icon show all
Pages 1063-1066 | Received 21 Mar 2022, Accepted 02 May 2022, Published online: 07 Jun 2022

References

  • Tzschentke TM, Christoph T, Kogel BY. The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol. CNS Drugs. 2014;28(4):319–329.
  • Baker DE. New drugs approved by the FDA; new dosage forms and indications approved by the FDA; agents pending FDA approval; new drug or biologics license applications filed by manufacturer; supplemental applications filed by manufacturer; significant labeling changes or “dear health care professional” letters related to safety. Hosp Pharm. 2009;44(2):179–190.
  • Peacock A, Gisev N, Memedovic S, et al. Opioid use and harms associated with a sustained-release tapentadol formulation: a post-marketing surveillance study. Drug Alcohol Depend. 2020;206:107697.
  • Chrzanowska AG, Price O, Sutherland R, et al. Tapentadol use and harms in Australia: analysis of opioid sales data and sentinel survey data from people who inject drugs. Drug Trends. 2020:1–26. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Tapentadol%20in%20Australia_final%202.pdf
  • Lam T, Hayman J, Berecki-Gisolf J, et al. Pharmaceutical opioid poisonings in Victoria, Australia: rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids. Addiction. 2022;117(3):623–636.
  • Darke S, Duflou J, Peacock A, et al. Characteristics of fatal tapentadol-related toxicity in Australia. Drug Alcohol Rev. 2022. DOI:10.1111/dar.13462
  • Cepeda MS, Fife D, Kihm MA, et al. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse. Clin J Pain. 2014;30(12):1051–1056.
  • Black J, Margolin ZR, Bau G, et al. Web-based discussion and illicit street sales of tapentadol and oxycodone in Australia: epidemiological surveillance study. JMIR Public Health Surveill. 2021;7(12):e29187.
  • Bohnert ASB, Ilgen MA. Understanding links among opioid use, overdose, and suicide. N Engl J Med. 2019;380(1):71–79.
  • Park TW, Saitz R, Ganoczy D, et al. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698.
  • Berling I, Whyte IM, Isbister GK. Oxycodone overdose causes naloxone responsive coma and QT prolongation. QJM. 2013;106(1):35–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.